Skip to search formSkip to main contentSkip to account menu

RP 59500

Known as: RP-59500 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

dalfopristin / quinupristin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
Influence of erythromycin resistance, inoculum growth phase, and incubation time on assessment of the bactericidal activity of RP 59500 (quinupristin-dalfopristin) against vancomycin-resistant…
RP 59500, a mixture of two semisynthetic streptogramin antibiotics (quinupristin and dalfopristin), is one of a few… 
1996
1996
Quinupristin-dalfopristin (RP 59500): an injectable streptogramin combination.
The pharmacology, pharmacokinetics, activity, and potential clinical role of quinupristin-dalfopristin (RP 59500) are described… 
1996
1996
RP 59500, a streptogramin derivative, is effective in murine listeriosis.
RP 59500 (Synercid) a streptogramin derivative, is a mixture of two water-soluble substances, RP 57669 (quinupristin), and RP… 
1995
1995
In vitro activity of RP 59500 (quinupristin/dalfopristin) and ramoplanin against vancomycin-resistant Enterococcus faecium.
Vancomycin-resistant Enterococcus faecium (VREF) collected between July 1991 and February 1994 were tested in vitro against RP… 
1995
1995
Bactericidal activity and kinetics of RP 59500 in a mouse model of Staphylococcus aureus septicaemia.
The bactericidal activity of RP 59500, a semisynthetic streptogramin, was compared with that of vancomycin against Staphylococcus… 
1992
1992
Comparative in-vitro activity of RP 59500.
The in-vitro activity of RP 59500 was compared with that of other appropriate antibiotics against 131 staphylococci, 97… 
1992
1992
In-vitro activity of RP 59500, a semisynthetic streptogramin, against staphylococci and streptococci.
The in-vitro activity of RP 59500, an injectable streptogramin derived from pristinamycin, was determined by agar dilution and… 
1992
1992
Post-antibiotic effects of RP 59500 with Staphylococcus aureus.
The post-antibiotic effect (PAE) of the semisynthetic streptogramin RP 59500 was evaluated with four clinical isolates of… 
1992
1992
The in-vitro activity of RP 59500 against gram-positive cocci.
RP 59500 was more potent than erythromycin, josamycin, amoxycillin and ciprofloxacin, and as potent as vancomycin, against… 
1992
1992
In-vitro activity of RP 59500, a new synergic antibacterial agent, against Legionella spp.
The in-vitro activity of RP 59500, a new semisynthetic injectable streptogramin, was compared with that of erythromycin… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)